Gujarat Themis Biosyn Ltd (GUJTHEM) — Board Meeting | 1 September 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board approved ₹335 crore preferential share issue
🔄 What Changed
₹335 crore capital raise via 8.21 million shares at ₹408/share
🔮 What's Next
Subject to shareholder and exchange approvals

Gujarat Themis Biosyn approved a preferential issue of up to 8,210,786 equity shares at ₹408 per share, raising ₹335 crore, subject to shareholder and exchange approvals. The issuance includes promoter and non-promoter investors, with allotment details in Annexure A.

📄 View Original Announcement (PDF)

About Gujarat Themis Biosyn Ltd (GUJTHEM)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹4,570.55 Cr

View full GUJTHEM stock details →

📡 Get AI alerts when GUJTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUJTHEM — Free

📊 More GUJTHEM filings

See all GUJTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GUJTHEM files new disclosures

Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GUJTHEM — Free

Free account · 2 AI queries/day